Intranasal Esketamine administration in catatonia: a case report.
Introduction Catatonia is a complex psychomotor syndrome that often goes unrecognized and, consequently, untreated. Prompt and correct identification of catatonia allows for highly effective treatment and prevention of possible complications. Benzodiazepines and electroconvulsive therapy (ECT) are...
Main Authors: | J. Romay, C. Sevilla, P. Hernandez, I. Lastra, G. Isidro, L. Cayon, G. Cortez, O. Anabitarte, P. Ijalba, M. Gomez Revuelta |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382302028X/type/journal_article |
Similar Items
-
The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01) -
Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01) -
Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01) -
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
by: Maria Pepe, et al.
Published: (2023-10-01) -
Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
by: A. Mercado-Rodríguez, et al.
Published: (2023-03-01)